Silk Road Medical, Inc. Common Stock
SILK
SILK was delisted on the 16th of September, 2024.
194 hedge funds and large institutions have $1.71B invested in Silk Road Medical, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 90 increasing their positions, 45 reducing their positions, and 32 closing their positions.
437% more call options, than puts
Call options by funds: $3.59M | Put options by funds: $669K
100% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 45
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 199 → 194 (-5)
13% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 32
19% less capital invested
Capital invested by funds: $2.12B → $1.71B (-$410M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$50M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$20.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$20M |
| 4 |
Renaissance Technologies
New York
|
+$16.4M |
| 5 |
DM
Deerfield Management
New York
|
+$16.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
TimesSquare Capital Management
New York
|
-$27.3M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$26.1M |
| 3 |
B
Braidwell
Stamford,
Connecticut
|
-$17.3M |
| 4 |
Amundi
Paris,
France
|
-$11.6M |
| 5 |
LCG
Lisanti Capital Growth
New York
|
-$11.6M |
SILK Hedge Fund Activity: Q1 2023 in Review
194 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q1 2023, worth a combined $1.71B — down 19% from $2.12B a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of SILK and 28 opened new positions — a net loss of 4 holders — while 45 trimmed existing stakes and 90 added.
The largest buyer was Fred Alger Management, opening a new position worth an estimated $50M. The largest seller was TimesSquare Capital Management, cutting an estimated $27.3M.
- 194 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q1 2023, down from 199 in Q4 2022.
- Funds reported $1.71B of Silk Road Medical, Inc. Common Stock stock for Q1 2023, down 19% quarter-over-quarter.
- 28 funds opened new Silk Road Medical, Inc. Common Stock positions in Q1 2023 and 32 closed out, a net change of -4 holders.
- The largest Silk Road Medical, Inc. Common Stock buyer in Q1 2023 was Fred Alger Management, an estimated $50M added.
- The largest Silk Road Medical, Inc. Common Stock seller in Q1 2023 was TimesSquare Capital Management, an estimated $27.3M sold.
Based on aggregated 13F filings for Q1 2023.